Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 04:06 ET | Source: Research and Markets

Diabetic Peripheral Neuropathy Market Report 2025-2035 - Pharmacological and Non-Pharmacological Innovations Expand Treatment Landscape for Diabetic Neuropathy

Dublin, May 07, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Peripheral Neuropathy Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has...
January 23, 2024 02:38 ET | Source: Research and Markets

Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...
November 07, 2022 05:53 ET | Source: Research and Markets

Global Diabetic Neuropathy Market Report 2022: Increasing Worldwide Incidence of Diabetes Bodes Well for Sector

Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetic Neuropathy Market, By Disorder, By Distribution Channel & By Region- Forecast and Analysis 2022-2028" report has been added to ...
October 25, 2022 06:33 ET | Source: Research and Markets

Global Peripheral Neuropathy Market Report 2022: Strategic Insight and Analysis of Key Drivers, Market Factors & Players

Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
September 23, 2022 06:53 ET | Source: Research and Markets

Peripheral Neuropathy Treatment Market Report 2022: Featuring Abbott, Eli Lilly, Pfizer, NeuroBo, Teva & Others

Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market, by Indication, by Treatment and Non-Pharmacological Therapies, by End-user, and by Region - Size, Share,...
July 14, 2022 06:33 ET | Source: Research and Markets

Chemotherapy Induced Peripheral Neuropathy Market 2028: Emerging Markets in Developing Countries Present Opportunities

Dublin, July 14, 2022 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel" report...
March 15, 2022 05:08 ET | Source: Research and Markets

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market to Cross $1.52 Billion by 2030 - What Are the Most Investment-Attractive Products, Segments, Applications, and Areas?

Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030" report has been added to...